AMR vs Latvia: Diphtheria tetanus toxoid and pertussis first-dose (DTP1)
AMR
92.0%
in 2025
Latvia
99.0%
in 2025
AMR rank
4th
Latvia rank
1st
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) over time
- AMR
- Latvia
How they compare
Latvia currently reports 99.0% against 92.0% in AMR, a difference of 7.0%.
That makes Latvia's figure about 1.1 times AMR's.
The two have swapped places 6 times across 26 shared years of data; in 2000 it was Latvia ahead.
AMR ranks 4th and Latvia ranks 1st of 11 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | AMR | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.8% | 98.1% | 1.3% | Latvia |
| 2010s | 95.0% | 96.5% | 1.5% | Latvia |
| 2020s | 89.7% | 98.3% | 8.7% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis first-dose (dtp1), AMR or Latvia?
- Latvia, at 99.0% against 92.0% in AMR as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis first-dose (dtp1) between AMR and Latvia?
- 7.0%, with Latvia ahead.
- How many years of comparable data are there for AMR and Latvia?
- 26 years are reported by both, from 2000 to 2025.
- How do AMR and Latvia rank globally for diphtheria tetanus toxoid and pertussis first-dose (dtp1)?
- AMR ranks 4th and Latvia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.